Consonance Capital Management LP Axogen, Inc. Transaction History

Consonance Capital Management LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$7.35 - $10.81 $26.2 Million - $38.5 Million	-3,566,054 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$8.38 - $17.34 $4.86 Million - $10.1 Million	579,668 Added 19.41%	3,566,054 $37.1 Million
Q4 2019 Feb 14, 2020	BUY	$11.18 - $18.6 $33.4 Million - $55.5 Million	2,986,386 New	2,986,386 $53.4 Million

151

37.3M

79.1K

500

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $530M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

Get notified when there are updates to the investment portfolio of Consonance Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Consonance Capital Management LP with notifications on news.